Key takeaway points The use of GLP-1 receptor agonists have become increasingly popular due to its weight loss benefit and the current production levels of these products are well below the demand levels globally
Used since 2005 primarily for people with type 2 diabetes, GLP-1 RAs have been very effective at improving markers like Hemoglobin A1c (HbA1c)
A well-designed companion app, combined with a secure cloud, admin portal and backend services can support data collection, support adherence, and accelerate reimbursement strategies
Looking ahead, the market is projected to reach approximately USD 268.37 billion by 2034, growing steadily at a strong CAGR of 17.5% from 2025 to 2034
You receive detailed injection or administration instructions, dosing protocols, and direct access to clinical support staff for questions or adjustments
Stuff the ricotta mix into each chicken breast